NCT01917916 - Single Rising Doses of BI 655064 in Healthy Chinese and Japanese Male Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 5, 2013

Primary Completion Date

May 14, 2014

Study Completion Date

May 14, 2014

Conditions

Healthy

Interventions

DRUG

Placebo

Solution for subcutaneous (s.c.) injection.

DRUG

BI 655064

Solution for subcutaneous (s.c.) injection.

Trial Locations (2)

1293.8.8101 Boehringer Ingelheim Investigational Site, Sumida-ku,Tokyo

1293.8.8201 Boehringer Ingelheim Investigational Site, Seoul